Health Care · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · CIK 1419554 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $0.90Day −5.89%Mkt cap $2M1Y −66.1%Off 52W high −78.1%Vol (1Y) 77.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,990 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest1.5% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)−0.06% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-14 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$2.9M |
| ROE−70.2% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−37.6% |
| 1Y−66.1% |
| 3Y−98.5% |
| 5Y−100.0% |
| 10Y−100.0% |
| Since incept. (ann.)−62.7% |
Total return through 2026-07-29 · series begins 2016-07-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)77.4% |
| Ann. volatility (3Y)141.6% |
| Sharpe (1Y)−1.19 |
| Sharpe (3Y)−0.42 |
| Max drawdown (1Y)−69.7% |
| Max drawdown (3Y)−98.7% |
| Beta (3Y vs SPY)1.79 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 4,126 | $4,539 | 0.23% | +22.1% |
| SBI Securities Co., Ltd. | 230 | $253 | 0.01% | +0.0% |
| UBS Group AG | 56 | $62 | 0.00% | −97.1% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$0.43 | — | — | — |
| 2025-09-30 | 2025-11-14 | −$0.37 | — | — | — |
| 2025-06-30 | 2025-08-14 | −$1.33 | — | — | — |
| 2025-03-31 | 2025-05-12 | — | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-14 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
